Skip to main content
Veterinary Medicines

PROTIVITY LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR CATTLE

Authorised
  • Water for injection
  • Mycoplasma bovis, strain N2805-1, Live

Product identification

Medicine name:
PROTIVITY LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR CATTLE
Protivity лиофилизат и разтворител за инжекционна суспензия за говеда
Active substance:
  • Water for injection
  • Mycoplasma bovis, strain N2805-1, Live
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Water for injection
    2.00
    millilitre(s)
    /
    1.00
    Dose
  • Mycoplasma bovis, strain N2805-1, Live
    2200000.00
    Colony forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AE05
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:
  • Type I hydrolytic glass vials containing 10 doses of lyophilisate or 20 ml of solvent.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Bulgarian Agency For Food Safety
Authorisation number:
  • 0022-3177
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0454/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Cyprus
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."